tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BMY Stock Latest News

Bristol Myers says Phase 3 ODYSSEY-HCM Camzyos trial did not meet endpoints
The FlyBristol Myers says Phase 3 ODYSSEY-HCM Camzyos trial did not meet endpoints
11h ago
BMY
Nu, HPE, Merck, BMY, OXY: Trending by Analysts
PremiumWeekend Updates
Nu, HPE, Merck, BMY, OXY: Trending by Analysts
3d ago
NU
BMY
Bristol Myers says FDA approves Opdivo plus Yervoy as first-line HCC treatment
PremiumThe Fly
Bristol Myers says FDA approves Opdivo plus Yervoy as first-line HCC treatment
3d ago
BMY
Bristol-Myers Squibb: Hold Rating Amid Mixed Revenue Projections and Market Challenges
PremiumRatings
Bristol-Myers Squibb: Hold Rating Amid Mixed Revenue Projections and Market Challenges
4d ago
BMY
Bristol Myers Squibb put volume heavy and directionally bearish
PremiumThe Fly
Bristol Myers Squibb put volume heavy and directionally bearish
5d ago
BMY
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
6d ago
BMY
ARTV
Bristol Myers wins dismissal of proposed Pomalyst class action, Reuters reports
Premium
The Fly
Bristol Myers wins dismissal of proposed Pomalyst class action, Reuters reports
6d ago
BMY
Morning Movers: Pharmaceuticals sink as impending tariffs seen coming
Premium
The Fly
Morning Movers: Pharmaceuticals sink as impending tariffs seen coming
6d ago
BMY
BTU
Bristol Myers price target lowered to $36 from $37 at Morgan Stanley
PremiumThe Fly
Bristol Myers price target lowered to $36 from $37 at Morgan Stanley
6d ago
BMY
Trump plans to announce ‘major’ tariff on pharmaceutical imports, Reuters says
PremiumThe Fly
Trump plans to announce ‘major’ tariff on pharmaceutical imports, Reuters says
6d ago
AZN
BMY
Artiva CMO Thorsten Graef switches to advisor role, Subhashis Banerjee succeeds
PremiumThe Fly
Artiva CMO Thorsten Graef switches to advisor role, Subhashis Banerjee succeeds
6d ago
BMY
ARTV
Bristol Myers says FDA approves Opdivo plus Yervoy as CRC treatment
PremiumThe Fly
Bristol Myers says FDA approves Opdivo plus Yervoy as CRC treatment
6d ago
BMY
FDA approves nivolumab with ipilimumab for additional indication
PremiumThe FlyFDA approves nivolumab with ipilimumab for additional indication
7d ago
BMY
Bristol-Myers Squibb: Hold Rating Amid Patent Expirations and Uncertain Growth Path
Premium
Ratings
Bristol-Myers Squibb: Hold Rating Amid Patent Expirations and Uncertain Growth Path
7d ago
BMY
Bristol Myers assumed with Neutral from Buy at Goldman Sachs
Premium
The Fly
Bristol Myers assumed with Neutral from Buy at Goldman Sachs
7d ago
BMY
Bristol Myers Squibb call volume above normal and directionally bullish
PremiumThe Fly
Bristol Myers Squibb call volume above normal and directionally bullish
12d ago
BMY
Halozyme: Bristol Myers receives positive CHMP opinion for Opdivo/Enhanze
PremiumThe Fly
Halozyme: Bristol Myers receives positive CHMP opinion for Opdivo/Enhanze
15d ago
BMY
HALO
Bristol-Myers Squibb: Hold Rating Maintained Amid Fair Valuation and Revenue Uncertainty
PremiumRatings
Bristol-Myers Squibb: Hold Rating Maintained Amid Fair Valuation and Revenue Uncertainty
15d ago
BMY
Bristol Myers announces CHMP opinion recommending Opdivo combination approval
PremiumThe Fly
Bristol Myers announces CHMP opinion recommending Opdivo combination approval
18d ago
BMY
Bristol Myers announces CHMP recommendation for Opdivo formulation approval
PremiumThe FlyBristol Myers announces CHMP recommendation for Opdivo formulation approval
18d ago
BMY
RFK Jr. plans to cut 10,000 jobs in HHS, WSJ reports
Premium
The Fly
RFK Jr. plans to cut 10,000 jobs in HHS, WSJ reports
19d ago
AZN
BMY
Large pharma M&A deals stalling amid volatile policies, Reuters reports
Premium
The Fly
Large pharma M&A deals stalling amid volatile policies, Reuters reports
20d ago
AZN
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >